Hsbc Holdings PLC Gilead Sciences, Inc. Transaction History

Hsbc Holdings PLC

  • $168 Billion
  • Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 4,161,516 shares of GILD stock, worth $375 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
4,161,516
Previous 5,324,369 21.84%
Holding current value
$375 Million
Previous $365 Million 4.51%
% of portfolio
0.21%
Previous 0.23%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$66.59 - $83.99 $77.4 Million - $97.7 Million
-1,162,853 Reduced 21.84%
4,161,516 $349 Million
Q2 2024

Aug 12, 2024
BUY
$63.15 - $72.88 $53.9 Million - $62.2 Million
853,524 Added 19.09%
5,324,369 $365 Million
Q1 2024

May 15, 2024
BUY
$71.58 - $87.29 $87.9 Million - $107 Million
1,227,652 Added 37.85%
4,470,845 $327 Million
Q4 2023

Feb 12, 2024
BUY
$73.27 - $83.09 $34.4 Million - $39 Million
468,942 Added 16.9%
3,243,193 $263 Million
Q3 2023

Nov 13, 2023
SELL
$73.94 - $80.67 $30.2 Million - $32.9 Million
-408,362 Reduced 12.83%
2,774,251 $208 Million
Q2 2023

Aug 11, 2023
BUY
$76.01 - $86.7 $29 Million - $33.1 Million
381,812 Added 13.63%
3,182,613 $245 Million
Q1 2023

May 15, 2023
SELL
$77.31 - $88.08 $57.4 Million - $65.4 Million
-742,978 Reduced 20.97%
2,800,801 $232 Million
Q4 2022

Feb 14, 2023
BUY
$62.32 - $89.47 $74.2 Million - $107 Million
1,191,060 Added 50.62%
3,543,779 $304 Million
Q3 2022

Nov 14, 2022
BUY
$59.54 - $68.01 $35.3 Million - $40.3 Million
592,794 Added 33.68%
2,352,719 $146 Million
Q2 2022

Aug 11, 2022
SELL
$57.72 - $65.01 $36 Million - $40.6 Million
-623,767 Reduced 26.17%
1,759,925 $109 Million
Q1 2022

May 16, 2022
BUY
$57.92 - $72.58 $54.7 Million - $68.6 Million
944,882 Added 65.67%
2,383,692 $142 Million
Q4 2021

Feb 11, 2022
SELL
$64.88 - $73.64 $9.5 Million - $10.8 Million
-146,395 Reduced 9.24%
1,438,810 $104 Million
Q3 2021

Nov 12, 2021
SELL
$67.69 - $73.03 $29.3 Million - $31.6 Million
-432,906 Reduced 21.45%
1,585,205 $111 Million
Q2 2021

Aug 13, 2021
SELL
$63.47 - $69.35 $34.1 Million - $37.3 Million
-537,994 Reduced 21.05%
2,018,111 $139 Million
Q1 2021

May 14, 2021
SELL
$60.0 - $68.46 $14.2 Million - $16.2 Million
-236,575 Reduced 8.47%
2,556,105 $165 Million
Q4 2020

Feb 25, 2021
SELL
$56.65 - $64.55 $6.09 Million - $6.94 Million
-107,500 Reduced 3.71%
2,792,680 $163 Million
Q4 2020

Feb 12, 2021
BUY
$56.65 - $64.55 $33.8 Million - $38.5 Million
597,109 Added 25.93%
2,900,180 $169 Million
Q3 2020

Nov 12, 2020
SELL
$62.1 - $78.08 $5.32 Million - $6.68 Million
-85,591 Reduced 3.58%
2,303,071 $145 Million
Q2 2020

Aug 14, 2020
BUY
$72.34 - $84.0 $28.2 Million - $32.7 Million
389,195 Added 19.46%
2,388,662 $184 Million
Q1 2020

May 15, 2020
BUY
$62.63 - $80.22 $2.92 Million - $3.75 Million
46,691 Added 2.39%
1,999,467 $150 Million
Q4 2019

Feb 14, 2020
SELL
$61.62 - $67.78 $6.11 Million - $6.72 Million
-99,154 Reduced 4.83%
1,952,776 $127 Million
Q3 2019

Nov 14, 2019
BUY
$62.51 - $69.0 $26 Million - $28.6 Million
415,183 Added 25.37%
2,051,930 $130 Million
Q2 2019

Aug 13, 2019
SELL
$61.87 - $69.38 $57.6 Million - $64.6 Million
-931,100 Reduced 36.26%
1,636,747 $111 Million
Q1 2019

May 15, 2019
BUY
$62.53 - $70.05 $24.4 Million - $27.3 Million
389,670 Added 17.89%
2,567,847 $167 Million
Q4 2018

Feb 13, 2019
SELL
$60.54 - $79.0 $4.87 Million - $6.35 Million
-80,435 Reduced 3.56%
2,178,177 $136 Million
Q3 2018

Nov 13, 2018
SELL
$71.28 - $78.92 $17.4 Million - $19.3 Million
-244,802 Reduced 9.78%
2,258,612 $174 Million
Q2 2018

Aug 10, 2018
SELL
$64.88 - $75.68 $39.5 Million - $46.1 Million
-608,822 Reduced 19.56%
2,503,414 $177 Million
Q1 2018

May 11, 2018
SELL
$72.84 - $88.8 $22.6 Million - $27.6 Million
-310,802 Reduced 9.08%
3,112,236 $235 Million
Q4 2017

Feb 14, 2018
BUY
$71.15 - $83.52 $48 Million - $56.3 Million
674,320 Added 24.53%
3,423,038 $245 Million
Q3 2017

Nov 14, 2017
SELL
$72.11 - $85.47 $4.36 Million - $5.17 Million
-60,441 Reduced 2.15%
2,748,718 $223 Million
Q2 2017

Aug 14, 2017
BUY
N/A
2,809,159
2,809,159 $199 Million

Others Institutions Holding GILD

# of Institutions
1,923
Shares Held
994M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email